Non-lactational periareolar infection

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Periductal mastitis is inflammation of the major ducts beneath the areola, most often affecting people who are not breastfeeding. Smoking is a strong association and contributes to squamous metaplasia, keratin debris and duct obstruction. Rupture releases keratin and bacteria into surrounding tissue, provoking a mixed inflammatory response that can include anaerobes. Recurrent episodes commonly appear at the same periareolar location.

Treatment has an acute and a definitive phase. Acute cellulitis receives appropriate antibiotics, while an abscess requires ultrasound-guided aspiration, catheter or operative drainage. Once inflammation settles, a persistent fistula or repeated same-site infection indicates an anatomical duct problem and merits specialist excision planning. Throughout the pathway, persistent mass, retraction or skin oedema must be re-imaged and biopsied when infection no longer accounts for the clinical picture.

Key points

Non-lactational periareolar infection arises around major subareolar ducts and differs from lactational mastitis in microbial mix, recurrence pattern and association with smoking.
Squamous metaplasia and keratin plugging can rupture a duct, producing painful subareolar inflammation, abscess and eventually a mammary duct fistula at the areolar edge.
Assess smoking, diabetes, immune compromise, prior abscesses and procedures, then use ultrasound to identify fluid and distinguish a collection from a persistent solid lesion.
Drain organised pus and send a deep specimen for culture; superficial swabs from a chronic sinus may not represent the organisms within the cavity.
The cited NHS Dumfries & Galloway pathway uses co-amoxiclav 500/125 mg orally three times daily for 10–14 days for central periductal infection, adjusted for allergy, culture and severity.
Recurrent abscess or fistula needs cessation support and specialist diseased-duct excision after acute sepsis is controlled; repeated antibiotics alone do not correct duct obstruction.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Smoking-associated metaplasia

Tobacco exposure is strongly associated with squamous change and keratin accumulation in major subareolar ducts centrally.

Host and duct factors

Diabetes, immune compromise, piercing and previous duct injury can promote bacterial entry, impaired healing and recurrent central infection.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Keratin obstruction
Squamous debris blocks the duct lumen, increasing pressure and damaging the duct wall beneath the nipple.
2
Rupture and mixed infection
Keratin and bacteria escape into periductal tissue, causing intense inflammation that may liquefy into a mixed aerobic-anaerobic abscess.
3
Fistula formation
Repeated rupture or surgical drainage creates a track between pathological duct and periareolar skin that can epithelialise and persist.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Central painful inflammation

Tender erythema and induration beneath or beside the areola suggest periductal disease; fluctuation or pointing identifies probable abscess.

Recurrent areolar opening

An intermittently draining sinus at the areolar margin after previous abscess is typical of a mammary duct fistula connecting skin to the diseased duct.

Host and exposure pattern

Current smoking, diabetes, obesity, immune suppression and nipple piercing can affect causation, healing and recurrence and should be recorded without blame.

Red flags requiring action

A persistent retroareolar mass, fixed inversion or peau d’orange after infection treatment requires urgent cancer assessment and representative tissue diagnosis.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Retroareolar ultrasoundFirst step
Why
Map dilated ducts, inflammatory tissue, abscess and any separate solid component.
Interpretation and limitations
Drainable fluid prompts source control; a hypoechoic mass without liquefaction or a vascular component needs tissue diagnosis rather than repeated aspiration.
02
Deep pus microbiology
Why
Identify aerobic and anaerobic organisms and guide treatment after drainage.
Interpretation and limitations
Prior antibiotics reduce yield and superficial sinus flora may mislead. Culture results are reconciled with response and local resistance patterns.
03
Glucose and host assessment
Why
Identify diabetes or immune compromise contributing to severe or recurrent infection.
Interpretation and limitations
Testing is directed by clinical context and recurrence. A high glucose changes infection management but does not itself explain a persistent breast mass.
04
Post-inflammatory breast imaging and core
Why
Exclude carcinoma or granulomatous disease when tissue does not return to normal.
Interpretation and limitations
Allow enough acute oedema to improve when clinically safe, then target residual abnormal tissue; benign inflammation must match the exact imaging lesion.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Duct ectasia without infection

Dilated ducts can cause coloured discharge and inversion without fever, cellulitis or an abscess cavity and do not automatically require antibiotics.

Inflammatory breast cancer

Diffuse persistent skin oedema, mass and nodes without resolving pus require urgent cancer imaging and biopsy.

Granulomatous mastitis

Sterile lobulocentric inflammation can cause recurrent abscesses and sinuses and requires microbiological exclusion before immune treatment.

Additional chapter-specific clues

Malignant mimic

Inflammatory cancer may appear infected. No fever, absent collection, abnormal nodes or failure to resolve after appropriate care increases concern.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01Central infection pathwayTreat cellulitis and search for pusFirst stepA non-lactating smoker has three days of periareolar pain and erythema with a deep tender thickening but stable observations.

1Assess severity, diabetes, allergy, previous organisms and any nipple piercing, then examine for fluctuation, fistula and cancer warning signs.
2Arrange targeted ultrasound promptly because a deep central collection may not fluctuate and would require drainage.
3When local criteria support oral treatment, use co-amoxiclav 500/125 mg three times daily for 10–14 days under the cited NHS Dumfries & Galloway pathway and adjust to culture.
4Review early enough to identify spreading disease or collection formation, with clear same-day return instructions for systemic deterioration.

02Fistula pathwayMove from repeated episodes to definitive careDefinitiveA fourth same-site abscess has drained through a chronic periareolar sinus and acute cellulitis is now improving.

1Compile prior imaging, cultures and incision sites and document current smoking and the anatomical position of both nipple duct and skin opening.
2Confirm acute cavity resolution, support smoking cessation and optimise diabetes or other healing risks before elective intervention.
3Discuss excision of the affected duct and fistulous tract with the breast surgeon, including scar, altered sensation, wound breakdown and recurrence.
4Review final histology and provide a route for rapid assessment of new swelling rather than another automatic prescription.

03Treatment-failure pathwayChallenge the infection diagnosisErythema improves but a firm retroareolar mass and nipple retraction persist after adequate drainage and antibiotics.

1Repeat examination and ultrasound to distinguish residual cavity, scar and solid tissue, and obtain age-appropriate mammography.
2Core the residual mass or sample abnormal skin using the modality that shows the target, including microbiological studies when granulomatous disease is possible.
3Refer urgently through the breast multidisciplinary pathway if findings suggest inflammatory or central carcinoma.
4Explain that infection has been treated but has not yet explained the persistent mass, and track the biopsy to concordance.

Key medicines and prescribing safety1 treatment · regimens, roles and cautions

Provides broad aerobic and anaerobic coverage while drainage addresses any organised periareolar abscess.

Co-amoxiclav

NHS Dumfries & Galloway uses co-amoxiclav 500/125 mg orally three times daily for 10–14 days for central periductal infection. This standard adult tablet schedule assumes weight at least 40 kg, CrCl above 30 mL/min and no contraindication; take the selected Sandoz tablets with a meal. Review clinical response and do not extend beyond 14 days without reassessment.

Contraindicated with hypersensitivity to the product or penicillins, a previous severe immediate reaction to another beta-lactam, or prior amoxicillin/clavulanate-associated jaundice or hepatic impairment. Serious delayed penicillin reactions also preclude routine reuse. At CrCl 10–30 mL/min use 500/125 mg twice daily; below 10 use it once daily, with a separately prescribed dialysis schedule when applicable. Existing hepatic impairment needs cautious dosing and regular liver monitoring. Check warfarin/INR on addition or withdrawal, methotrexate toxicity and mycophenolate clinical monitoring; probenecid coadministration is not recommended. Stop and assess significant allergic or severe diarrhoeal reactions. Culture and severity guide treatment; this outpatient example does not cover sepsis or presumed resistant infection.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Recurrent abscess

The obstructed duct remains a source for repeated collections despite temporary drainage and short antimicrobial courses.

Mammary duct fistula

A chronic skin opening discharges intermittently, causes pain and scarring and commonly requires definitive duct-tract excision.

Nipple and skin distortion

Fibrosis, recurrent incision and inflammation alter nipple position and breast contour while making cancer assessment more difficult.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Mark erythema borders and record pain, temperature and collection size so worsening infection is recognised promptly.
Review culture results and modify antibiotics rather than extending broad treatment automatically when resistant or unusual organisms appear.
Confirm abscess collapse and resolution of the underlying retroareolar mass after acute inflammation settles.
Track recurrent fistula patients from cessation support through elective review, histology and wound healing because temporary closure is not cure.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Microbiology can be mixed

Central non-lactational infection may include anaerobes as well as staphylococci, which is why its empirical pathway differs from uncomplicated lactational mastitis.

Sinus closure can deceive

A fistula may seal between episodes while the obstructed duct remains. Repeated reopening at the same areolar site reveals persistent anatomy.

Smoking affects mechanism and healing

Cessation addresses duct pathology association and reduces surgical wound risk; it should be offered respectfully rather than used to deny care.

Inflammation needs an endpoint

The breast should return toward baseline after successful treatment. Residual inversion, mass or oedema demands diagnostic resolution, not a permanent infection label.

11Common pitfallsFrequent interpretation and management errors.

01
Applying a lactational mastitis regimen automatically ignores the anaerobic and recurrent-duct context of central periductal disease.
02
Swabbing only a draining skin opening may identify colonisers rather than organisms within the abscess.
03
Giving antibiotics without ultrasound and drainage for organised pus produces incomplete source control.
04
Repeatedly calling persistent retraction inflammatory can delay diagnosis of a central carcinoma.

Find your next topic